Futura

Views & Analysis

Though PDE5 inhibitor drugs like Viagra have dominated the sexual health market for decades, the treatments come with some severe disadvantages.

News

Novartis has reported new data to support its drive to expand the label of its radioligand therapy Pluvicto in prostate cancer.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.